Mouse models for pRB growth control via E2F/DP action
Mouse models for pRB growth control via E2F/DP action
批准号:
7612637
负责人:
Lili Yamasaki
金额:
$34.15万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-07 至 2010-04-30
关键词:
AllelesBindingCCAAT-Enhancer-Binding ProteinsCell Cycle ProgressionCell Cycle RegulationComplexCyclinsDevelopmentDifferentiation and GrowthEmbryoEmbryonic DevelopmentFamilyFamily memberGeneticGerm LinesGrowthHumanIn VitroIndividualKnock-in MouseKnock-outKnockout MiceLeadLifeMediatingMusMutationNeuronsPathway interactionsPhosphorylationPredispositionProliferation MarkerReporterRepressionRetinaRetinoblastoma ProteinSeriesSignal TransductionSiteSmall Interfering RNATestingTissuesTransgenesTransgenic OrganismsWorkembryo tissuein vivomouse modelmutantnovelprogramspromoterretinoblastoma tumor suppressorstemtranscription factortumortumor progressiontumorigenesis
中文摘要
描述(由申请人提供):人(RB)和小鼠(RB)视网膜母细胞瘤肿瘤抑制因子的失活促进肿瘤进展。在很大程度上,pRB通过抑制E2F/DP家族复合物来调节生长,其中一个子集在游离时刺激细胞周期进程。相反,pRB通过调节负责特定分化程序的转录因子(例如MyoD、C/EBP、CBFA1的激活)来刺激分化。然而,pRB的缺失并不会影响所有组织的发育,种系RB或RB突变会导致高度渗透的、组织特异性的肿瘤易感性。在体外,Gl Cyclin/ cdk介导的磷酸化程度决定了pRB抑制细胞周期进展的能力;然而,最近证明Gl细胞周期蛋白和Cdks对于大多数组织的正常发育是不可缺少的;提出了一个问题,即在体内正常调节pRB/E2F/DP通路的“线路”是什么?pRB(在pRB家族中)独特的肿瘤抑制功能可能源于其协调生长抑制与特定谱系承诺的能力。只有通过识别在体内运作的信号,我们才能理解Rb的缺失是如何破坏关键组织的发育并促进特定部位的肿瘤发生的。首先,利用我们的一系列新的野生型和突变Rb启动子转基因基因和一个新的Rb启动子敲入等位基因,我们将确定正常调节Rb神经元特异性表达的激活因子和抑制因子,并在体外和体内测试Rb表达失调的功能后果(Aim 11)。其次,我们将通过sirna介导的DP家族表达敲低和条件Dpi和/或Dp2敲除小鼠的建立,确定整个DP家族及其个体家族成员(Dpi和Dpi)在细胞周期控制和胚胎发育中的要求(Aim 2)。
英文摘要
DESCRIPTION (provided by applicant): Inactivation of the retinoblastoma tumor suppressor in humans (RB) and in mice (Rb) facilitates neoplastic progression. To a large part, pRB regulates growth by repressing E2F/DP famil) complexes, a subset of which when free, stimulates cell cycle progression. Instead, pRB stimulates differentiation by regulating transcription factors responsible for specific differentiation programs (e.g., activation of MyoD, C/EBP, CBFA1). Yet, loss of pRB does not compromise the development of all tissues, and germ-line RB or Rb mutations lead to highly penetrant, tissue specific tumor predisposition. In vitro, the extent of Gl Cyclin/Cdk-mediated phosphorylation governs the ability of pRB to restrain cell cycle progression; however, the recently demonstrated dispensability of Gl Cyclins and Cdks for the normal development of most tissues; raises the question of what is the "wiring" that normally regulates the pRB/E2F/DP pathway in vivo. It is likely that the unique tumor suppressive function of pRB (among pRB family numbers) stems from its ability to coordinate growth inhibition with specific lineage commitment. Only by identifying the signals operating in vivo can we understand how loss of Rb disrupts the development of key tissues and facilitates tumorigenesis at specific sites. First, using our novel series of wildtype and mutant Rb promoter transgenics and a new Rb promoter knock-in allele, we will identify the activators and repressors that normally regulate the neuronal-specific expression of Rb and test the functional consequences of deregulating Rb expression in vitro and vivo (Aim 11. Second, we will define a requirement for the entire DP family and its individual family members (Dpi and Dpi) in cell cycle control and embryonic development through siRNA-mediated knockdown of DP family expression and the establishment of conditional Dpi and/or Dp2 knockout mice (Aim 2).
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1.
p53 缺陷小鼠的淋巴瘤发生和雌性特异性致死率的发生与 E2f1 无关。
DOI:
10.1038/ncb0704-565
发表时间:
2004
期刊:
Nature cell biology
影响因子:
21.3
作者:
[Wloga,ElzbietaH, Criniti,Vittoria, Yamasaki,Lili, Bronson,RoderickT]
通讯作者:
Bronson,RoderickT
Modeling cell cycle control and cancer with pRB tumor suppressor.
使用 pRB 肿瘤抑制因子模拟细胞周期控制和癌症。
DOI:
10.1007/b136682
发表时间:
2006
期刊:
Results and problems in cell differentiation
影响因子:
--
作者:
[Yamasaki,Lili]
通讯作者:
Yamasaki,Lili
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:6342111
-
项目类别:
-
资助金额:$33.89万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
Mouse models for pRB growth control via E2F/DP action
-
批准号:7236241
-
项目类别:
-
资助金额:$34.05万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
Mouse models for pRB growth control via E2F/DP action
-
批准号:7069060
-
项目类别:
-
资助金额:$32.99万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:6626616
-
项目类别:
-
资助金额:$35.96万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:2728433
-
项目类别:
-
资助金额:$28.91万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:6137687
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:6496879
-
项目类别:
-
资助金额:$1.31万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
Mouse models for pRB growth control via E2F/DP action
-
批准号:7486842
-
项目类别:
-
资助金额:$34.12万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
Mouse models for pRB growth control via E2F/DP action
-
批准号:6968505
-
项目类别:
-
资助金额:$33.73万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
MOUSE MODELS FOR PRB GROWTH CONTROL VIA E2F/DP ACTION
-
批准号:6489161
-
项目类别:
-
资助金额:$34.91万
-
财政年份:1999
-
负责人:Lili Yamasaki
-
依托单位:
RETINOBLASTOMA PROTEIN-E2F REPRESSION AND GROWTH CONTROL
-
批准号:2101211
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1995
-
负责人:Lili Yamasaki
-
依托单位:
RETINOBLASTOMA PROTEIN-E2F REPRESSION AND GROWTH CONTROL
-
批准号:2101210
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1994
-
负责人:Lili Yamasaki
-
依托单位:
RETINOBLASTOMA PROTEIN-E2F REPRESSION & GROWTH CONTROL
-
批准号:2101209
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1993
-
负责人:Lili Yamasaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: